<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CVM
CEL-SCI
$
()


  • CEL-SCI: LEAPS vaccine offers 'new paradigm to treat' RA published in Frontiers

    3/19/2024 - 09:14am
  • CEL-SCI issues letter to shareholders regarding Multikine cancer therapy

    3/6/2024 - 09:18am
  • CEL-SCI 3.875M share Secondary priced at $2.00

    2/9/2024 - 08:32am
  • CEL-SCI announces Multikine cGMP dedicated facillity commissioning completed

    2/6/2024 - 09:06am
  • EMA grants CEL-SCI waiver 'clearing' marketing authorization path for Multikine

    1/31/2024 - 09:25am
  • Biotech Alert: Searches spiking for these stocks today

    12/6/2023 - 11:17am
  • Largest borrow rate increases among liquid names

    11/30/2023 - 08:45am
  • Largest borrow rate increases among liquid names

    11/29/2023 - 08:45am
  • Largest borrow rate increases among liquid names

    11/28/2023 - 08:45am
  • CEL-SCI prices $5M offering of common stock at $2.00 per share

    11/16/2023 - 08:32am
  • CEL-SCI issues letter to shareholders regarding Multikine regulatory pathway

    10/30/2023 - 09:25am
  • Biotech Alert: Searches spiking for these stocks today

    10/25/2023 - 11:08am
  • CEL-SCI presents data for immunotherapy drug Multikine at ESMO

    10/23/2023 - 09:29am
  • CEL-SCI requests to discuss pathway for Multikine immunotherapy with MHRA

    10/5/2023 - 08:48am
  • Cel Sci options imply 17.7% move in share price post-earnings

    8/11/2023 - 13:49pm
dynamic_feed Breaking News